en
Kolibri's project aims to address the weaknesses in respiratory care in Germany, as 10% of the population suffers from respiratory diseases, including asthma and COPD.
The project targets challenges such as uncontrolled particle deposition, high risks in clinical development, patient acceptance and adherence. OECHSLER & PULMOTREE aim to develop innovative solutions to optimize drug delivery, mitigate risks, and enhance patient experiences. This project is a testimony to OECHSLER’s pioneering spirit and paves the way for a brighter future in respiratory health through advancements in drug delivery technology.